Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen A Christie

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Trends in Genetics : TIG|September 26, 2021
Making the cut with PAMless CRISPR-Cas enzymesKathleen A Christie, Benjamin P Kleinstiver
Progress in Retinal and Eye Research|January 30, 2018
Personalised genome editing - The future for corneal dystrophiesC B Tara Moore, Kathleen A Christie, John Marshall, et al.
Science (New York, N.Y.)|March 29, 2020
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variantsRussell T Walton, Kathleen A Christie, Madelynn N Whittaker, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 17, 2020
Gene Editing for Corneal Stromal RegenerationTara Moore, Connie Chao-Shern, Larry DeDionisio, et al.
Nature Microbiology|April 25, 2020
Author Correction: Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transferCaroline Mahendra, Kathleen A Christie, Beatriz A Osuna, et al.
Nature Microbiology|March 29, 2020
Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transferCaroline Mahendra, Kathleen A Christie, Beatriz A Osuna, et al.
Cell Host & Microbe|April 24, 2020
Listeria Phages Induce Cas9 Degradation to Protect Lysogenic GenomesBeatriz A Osuna, Shweta Karambelkar, Caroline Mahendra, et al.
Scientific Reports|November 25, 2017
Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disordersKathleen A Christie, David G Courtney, Larry A DeDionisio, et al.
Proteomics. Clinical Applications|June 20, 2020
Protein Analysis of the TGFBI<sup>R124H</sup> Mouse Model Gives Insight into Phenotype Development of Granular Corneal DystrophyMarie V Lukassen, Ebbe T Poulsen, Jack Donaghy, et al.
Molecular Therapy. Nucleic Acids|September 3, 2019
Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating PeptideDavide Schiroli, María J Gómara, Eleonora Maurizi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Trends in Genetics : TIG|September 26, 2021
Making the cut with PAMless CRISPR-Cas enzymesKathleen A Christie, Benjamin P Kleinstiver
Progress in Retinal and Eye Research|January 30, 2018
Personalised genome editing - The future for corneal dystrophiesC B Tara Moore, Kathleen A Christie, John Marshall, et al.
Science (New York, N.Y.)|March 29, 2020
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variantsRussell T Walton, Kathleen A Christie, Madelynn N Whittaker, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 17, 2020
Gene Editing for Corneal Stromal RegenerationTara Moore, Connie Chao-Shern, Larry DeDionisio, et al.
Nature Microbiology|April 25, 2020
Author Correction: Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transferCaroline Mahendra, Kathleen A Christie, Beatriz A Osuna, et al.
Nature Microbiology|March 29, 2020
Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transferCaroline Mahendra, Kathleen A Christie, Beatriz A Osuna, et al.
Cell Host & Microbe|April 24, 2020
Listeria Phages Induce Cas9 Degradation to Protect Lysogenic GenomesBeatriz A Osuna, Shweta Karambelkar, Caroline Mahendra, et al.
Scientific Reports|November 25, 2017
Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disordersKathleen A Christie, David G Courtney, Larry A DeDionisio, et al.
Proteomics. Clinical Applications|June 20, 2020
Protein Analysis of the TGFBI<sup>R124H</sup> Mouse Model Gives Insight into Phenotype Development of Granular Corneal DystrophyMarie V Lukassen, Ebbe T Poulsen, Jack Donaghy, et al.
Molecular Therapy. Nucleic Acids|September 3, 2019
Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating PeptideDavide Schiroli, María J Gómara, Eleonora Maurizi, et al.
Pageof 2